Life Sciences
Global pharma has a structural content problem: material gets made centrally, then localised slowly and expensively, and the people it is meant to serve wait. My answer has been to build systems rather than assets.
D:CAM - Digital Content Acceleration Methodology
Speed is a compliance problem as much as a creative one. D:CAM, the methodology I created alongside GME:X, cut content cost and time-to-market by 80% while keeping every item fully compliant.
That balance is not new for me: as a signatory I have approved roughly 450 regulated items at AstraZeneca and 150 at Sanofi, with zero breaches across both.
Patients, not just professionals
Content systems should serve the people at the end of the healthcare chain. I led digital content and strategy for The Heart & Kidney Care Alliance, which is Bayer-funded but patient-led, and unites more than 22 patient organisations globally.
AAKP Award 2025
Global Medal of Excellence in Kidney Science and Patient-Centered Medicine
At the AAKP 2025 Global Summit, Bayer received the Global Medal of Excellence in Kidney Science and Patient-Centered Medicine. The medal was awarded to Bayer as a company, not to any individual, and Christine Roth accepted it on Bayer’s behalf. Dr Kishan Rees joined Colin Prout as a speaker in the accompanying Bayer session. The full programme and speaker line-up appear in the official AAKP 2025 agenda.
Measurement: knowing what works
A content system you cannot measure is a content opinion. Across these platforms I have run A/B message testing in the US and Japan, including dubbed audio variants, integrated content into Veeva Vault omnichannel workflows, and built marketing-mix modelling with live dashboards that connect educational content to outcomes.
GME:X - Global Medical Education Xchange
At Bayer I built GME:X, a global medical education platform, and took it live across four markets: the US, Japan (fully translated), India and the UK. It has reached more than 50,000 healthcare professionals. I staffed it with a deliberately early-career team, because building the next generation of builders was part of the point.
One of the judges who later reviewed this work described it as:
disrupting the global-local model and switching it around to focus on the country’s needs first. Judge Mike Orriss, via Pharmafile
Where it started
The systems thinking predates Bayer. At AstraZeneca I designed three digital platforms, for HCP education, collaboration and change management, and won the EU-Canada Medical Innovation Award, £75,000 of funding, by competitive pitch. At Sanofi I led a team of 14 and grew monthly HCP engagement by 147%, from 1,700 to 4,200.
In 2025 the PM Society named me Pharma Marketing Pioneer. The judges’ words, not mine:
Kishan is a pioneer in the true sense of the word. PM Society Awards judges, Pharma Marketing Pioneer 2025
The GME:X and Heart & Kidney Care Alliance logos are © Bayer AG.